07MADRID497
SPANISH COMPONENT OF U.S./FDA ORPHAN PRODUCT
Fri Mar 16 00:00:00 +0100 2007
UNCLASSIFIED
Embassy Madrid
VZCZCXYZ0001
RR RUEHWEB

DE RUEHMD #0497 0750755
ZNR UUUUU ZZH
R 160755Z MAR 07
FM AMEMBASSY MADRID
TO RUEHC/SECSTATE WASHDC 2101
INFO RUEHRL/AMEMBASSY BERLIN 0611
RUEHBY/AMEMBASSY CANBERRA 0855
RUEHLO/AMEMBASSY LONDON 0867
RUEHOT/AMEMBASSY OTTAWA 2738
RUEAUSA/DEPT OF HHS WASHDCUNCLAS MADRID 000497 
 
SIPDIS 
 
SIPDIS 
 
HHS PASS TO FDA OFFICE OF INTERNATIONAL PROGRAMS (ELAINE 
FOSTER) 
 
E.O. 12958: N/A 
TAGS: TBIO OTRA TPHY KSCA SP
SUBJECT: SPANISH COMPONENT OF U.S./FDA ORPHAN PRODUCT 
DEVELOPMENT GRANT AWARD 
 
REF: SECSTATE 30378 
 
Embassy Madrid is aware of no concerns or objections 
regarding the foreign policy implications of reftel grant. 
Embassy checked with the two Spanish institutions listed as 
participating in the grant award.  Dr. Justo Garcia de 
Yebenes of the Ramon and Cajal Hospital confirmed that he 
leads a team that will work on this project.  However, Dr. 
Asuncion Martinez of the Jimenez Diaz Foundation indicated 
that her foundation would not participate.  She indicated 
that she understood that Dr. de Yebenes of the Ramon and 
Cajal Hospital would participate in the project. 
Llorens